Eli Lilly says experimental drug slows Alzheimer's worsening
Donanemab is designed to target and clear away a sticky protein called beta-amyloid that builds up into brain-clogging plaques that are one hallmark of Alzheimer’s.
- Live Doppler 13 Radar
- Advertise With Us
- Delphi Murders Trial
- Operation Football
- 13 Investigates
- VERIFY
- What's The Deal Consumer Reports
- Traffic
- 13 Weather Academy
- Send The Love
- Inspiring Indiana
- TV Schedule
- Meet The Team
- 13INside Track
- Download the news app
- FCC Public File
- EEO Public File
- Closed Captioning Help